Innovative Molecules
Munich
About Innovative Molecules
Innovative Molecules develops drugs designed to treat Herpes simplex-induced diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: innovativemolecules.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/innovative-molecules-98955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.